$EW News
Last published 2d ago
- 2d agoJNJVRTXHUMEW+1Raised Outlooks and a Cancer Approval Arrive in the Middle of Medicare Open EnrollmentPR NewswireMarket Updates News Commentary - Health care stocks moved higher with the broader market on Monday morning. As of 9:58 a.m. ET, the State...
- 1w agoEWEdwards Lifesciences Corp - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoEWTCT TAVR and TMTT Investor Q&A - EDWARDS LIFESCIENCES CORPEarnings Call Transcriptswelcome everyone and thank you for being here before I turn it over to Bernard to make some opening remarks please take some time a moment to familiarize yourself with our cautionary statement you guys all know this it's
- 3w agoEWFDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve DiseaseBusiness WireRecent FDA Approval of PASCAL Ace with Capture Clarity Simplifies Mitral TEER Procedures for Clinicians Edwards Lifesciences Corporation (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has
- 1mo agoEWEdwards Lifesciences to Host Earnings Conference Call on November 4, 2026Business WireEdwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4, and will host a conference call at 5:00 p.m. ET that day to
- 1mo agoEWEdwards Lifesciences to Host Investor Event in Conjunction With TCTBusiness WireEdwards Lifesciences (NYSE:EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting
- 1mo agoEWEdwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric PatientsBusiness WireEdwards Lifesciences (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with
- 1mo agoEWFDA Approves First Heart Valve Designed to Grow with ChildrenFDA Press ReleasesThe U.S. Food and Drug Administration today approved the Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease. This innovative device may reduce the need for repeat open-heart surgeries in children with heart defects, reflecting the Trump Administration’s commitment to bringing breakthrough medical technologies to ...
- 1mo agoEWEdwards Lifesciences - 1774278 - EDWARDS LIFESCIENCES CORPEarnings Call TranscriptsGood morning, everyone. Thanks for joining us today. Very, very pleased to host Edwards Light Sciences. So this should be a fun event. I guess to start off with, before we start asking questions, do you want to have any
- 2mo agoEWEdwards Lifesciences Comments on TAVR National Coverage DecisionBusiness WireEdwards Lifesciences (NYSE:EW) today issued the following statement in response to the national coverage determination (NCD) for transcatheter aortic valve replacement (TAVR) released by the Centers for Medicare &
- 2mo agoEWEdwards Lifesciences to Present at the Deutsche Bank Healthcare SummitBusiness WireEdwards Lifesciences Corporation (NYSE:EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET.
- 2mo agoEWSystem Test Page - EDWARDS LIFESCIENCES CORPEarnings Call TranscriptsThank you for watching. Thank you. Thank you. We'll be right back. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. Thank you. piano plays softly Th
- 3mo agoEWEdwards Lifesciences Reports Second Quarter ResultsBusiness WireEdwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended June 30, 2026. Highlights Q2 sales grew 13.6% to $1.74 billion1, constant currency2 sales grew 12.5% Q2 TAVR sales grew
- 3mo agoEWEdwards Lifesciences to Host Earnings Conference Call on July 23, 2026Business WireEdwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended June 30, 2026 after the market closes on Thursday July 23, and will host a conference call at 5:00 p.m. ET that day to discuss
- 4mo agoEWEdwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York ValvesBusiness WireEdwards Lifesciences (NYSE:EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in
- 6mo agoEW2026 GLOBAL HEALTHCARE CONFERENCEEDWARDS LIFESCIENCES CORPEarnings Call Transcriptsnext up we have Edwards life sciences welcome Bernard thank you thanks for coming how are you doing good excellent good to be here hi everyone maybe I'll let you open I know you want to make some opening remarks to get s
- 6mo agoEWEdwards Lifesciences Announces Appointment of CFOBusiness WireEdwards Lifesciences (NYSE:EW) today announced the appointment of Theodora ("Doretta") Mistras as the company's corporate vice president and chief financial officer (CFO), effective at the end of May. Mistras will
- 6mo agoEWTen-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia TissueBusiness WireEdwards Lifesciences (NYSE:EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at
- 6mo agoEWEdwards Lifesciences to Present at the BofA Securities 2026 Health Care ConferenceBusiness WireEdwards Lifesciences (NYSE:EW) today announced it will participate in the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026. Bernard Zovighian, chief executive officer, will participate in a
- 6mo agoEWEdwards Lifesciences First Quarter 2026 ResultsEDWARDS LIFESCIENCES CORPEarnings Call TranscriptsGreetings, and welcome to the Edwards Life Sciences First Quarter 2026 results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone shoul
- 6mo agoEWEdwards Lifesciences Reports First Quarter ResultsBusiness WireEdwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended March 31, 2026. Highlights and Outlook Q1 sales grew 16.7% to $1.65 billion1, constant currency2 sales grew 12.7% Q1 TAVR
- 6mo agoBFLYEWHTFLIRTCThe Quiet Shift Replacing Million-Dollar Heart Scanners With SoftwareGlobeNewswireVANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global AI cardiology market is on track to hit $2.78 billion this year and climb past $14 billion by 2034, and the
- 6mo agoEWEdwards Lifesciences to Host Earnings Conference Call on April 23, 2026Business WireEdwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended March 31, 2026 after the market closes on Thursday April 23, and will host a conference call at 5:00 p.m. ET that day to
- 7mo agoEWTwo Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient BenefitsBusiness WireTRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover Edwards Lifesciences (NYSE:EW) today announced new data on the EVOQUE transcatheter
- 8mo agoEWEdwards Lifesciences Advances Structural Heart Care Through Innovation and PurposeBusiness WireAt the close of Heart Month, Edwards Lifesciences (NYSE:EW) underscored its leadership in structural heart innovation, advancing care through deep expertise and strong partnerships so people with structural heart
- 8mo agoEWEdwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare ConferencesBusiness WireEdwards Lifesciences Corporation (NYSE:EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences: Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th
- 9mo agoEWEdwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access DayBusiness WireEdwards Lifesciences Corporation (NYSE:EW) today announced it will participate in Citi's Unplugged Medtech and Life Sciences Access Day on February 26, 2026. Scott Ullem, chief financial officer, is scheduled to
- 9mo agoEWEdwards Lifesciences Reports Fourth Quarter ResultsBusiness WireEdwards Lifesciences (NYSE:EW) today reported financial results for the quarter and full-year ended Dec. 31, 2025. Highlights and Outlook Q4 sales grew 13.3% to $1.57 billion1, constant currency2 sales grew
- 9mo agoEWEdwards Lifesciences to Host Earnings Conference Call on February 10, 2026Business WireEdwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended December 31, 2025 after the market closes on Tuesday, February 10, and will host a conference call at 5:00 p.m. ET that day to
- 9mo agoEWEdwards Lifesciences to Present at the TD Cowen 46th Annual Health Care ConferenceBusiness WireEdwards Lifesciences Corporation (NYSE:EW) today announced it will participate in the TD Cowen 46th Annual Health Care Conference on Monday, Mar. 2, 2026. Scott Ullem, chief financial officer, is scheduled to present
- 9mo agoATRCCBLLEWHTFLAI Diagnostics: The End of the High-Cost Imaging EraGlobeNewswireVANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034[1]. This systemic
- 10mo agoEW2026 Edwards Lifesciences Annual Meeting of StockholdersEDWARDS LIFESCIENCES CORPEarnings Call TranscriptsWelcome to the Edwards Life Sciences 2026 Annual Meeting of Stockholders. I'll now turn it over to your host, the Chairman of the Board, Nick Valeriani. Good morning, and welcome to the 2026 annual meeting of stockholder
- 10mo agoEWFDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter TherapyBusiness WireEdwards Lifesciences (NYSE:EW) today announced the company's SAPIEN M3 mitral valve replacement system is the first transcatheter therapy utilizing a transseptal approach to receive U.S. Food and Drug Administration
- 10mo agoEWEdwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness WireEdwards Lifesciences Corporation (NYSE:EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026. Bernard Zovighian, chief executive officer, is scheduled to present at
- 11mo agoEWEdwards Lifesciences Innovation (Israel) Ltd. - Appeal, ReversedUS Patent Trial and Appeal Board
- 11mo agoEWEdwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor ConferenceBusiness WireInnovation with Purpose, Powered by Science, Centered on Patients: Edwards' Commitment to Drive Value for the Healthcare Ecosystem Edwards Lifesciences (NYSE:EW) will outline its patient-focused strategy and share
- 1y agoEWEdwards Champions American Heart Association Initiative to Reduce Deaths, Improve Care for Patients With Heart Valve DiseaseBusiness WireEdwards Lifesciences (NYSE:EW) today announced its founding sponsorship of the American Heart Association's Heart Valve Initiative, a national effort to improve care and outcomes for the more than 28 million people
- 1y agoEWEdwards Lifesciences Announces CFO Transition PlanBusiness WireEdwards Lifesciences (NYSE:EW) today announced that Scott Ullem, the company's chief financial officer, has decided to transition from his role by midyear 2026. While the company initiates a selection process to appoint
- 1y agoEWEdwards Lifesciences Reports Third Quarter ResultsBusiness WireEdwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended September 30, 2025. Recent Highlights Q3 sales grew 14.7% to $1.55 billion, or 12.6% adjusted1, with strength across all product
- 1y agoEWSuccessful Patient Outcomes Demonstrated With Edwards' SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025Business WireENCIRCLE mitral trial achieves primary and secondary endpoints EVOQUE tricuspid valve registry demonstrates more favorable outcomes than pivotal trial Edwards Lifesciences (NYSE:EW) today announced data demonstrating
- 1y agoEWEdwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025Business WireSAPIEN 3, which showed superiority at 1 year, also demonstrates compelling outcomes equivalent to surgery at seven years Edwards Lifesciences (NYSE:EW) today announced seven-year data from the PARTNER 3 trial,
- 1y agoEWEdwards Lifesciences to Host Earnings Conference Call on October 30, 2025Business WireEdwards Lifesciences (NYSE:EW) plans to announce its operating results for the quarter ended September 30, 2025 after the market closes on Thursday October 30, 2025, and will host a conference call at 5:00 p.m. ET that
- 1y agoEWCardiovalve Ltd vs Edwards Lifesciences Corp. et al. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 1y agoEWFRHCPMIPicard Announces Appointment of Two New Members to its Board of DirectorsGlobeNewswireTUCSON, Ariz., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE:PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first U.S. and Canadian commercially-approved
- 1y agoEWUpdated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease CareBusiness WireEdwards Lifesciences (NYSE:EW) welcomes the updated ESC/EACTS guidelines for valvular heart disease, which establish a simplified care pathway for all severe aortic stenosis (AS) patients, regardless of symptoms. The
- 1y agoEWPulnovo Medical Names Dr. Francis Duhay as Global Chief Medical OfficerPR NewswirePulnovo Medical, a global leader in mechanism-driven therapies for Pulmonary Hypertension (PH) and Heart Failure (HF), today announced the...
- 1y agoEWEdwards Lifesciences Announces $500 Million Accelerated Share RepurchaseBusiness WireEdwards Lifesciences (NYSE:EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards' common stock. With this transaction, Edwards has
- 1y agoEWEdwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValveBusiness WireEdwards Lifesciences (NYSE:EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company's proposed acquisition of JenaValve Technology. Edwards disagrees with FTC's decision and believes
- 1y agoEWEDWARDS LIFESCIENCES CORPORATION - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoEWEdwards Lifesciences Reports Second Quarter ResultsBusiness WireEdwards Lifesciences (NYSE:EW) today reported financial results for the quarter ended June 30, 2025. Recent Highlights Q2 sales grew 11.9% to $1.53 billion, or 10.6% adjusted1, with strength across all product